+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents, Instruments, Services), Technology (Immunoassay, Molecular Diagnostics), Application, End-use, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 358 Pages
  • December 2023
  • Region: United States
  • Grand View Research
  • ID: 5644935
Description Jump to:
The U.S. in vitro diagnostics market size is expected to reach USD 37.58 billion by 2030. The market is anticipated to grow at a CAGR of 3.70% from 2024 to 2030. Medical instruments that perform diagnostic tests on bio-fluids including blood, urine, and tissues are known as in vitro diagnostics (IVD). The IVD tests are used to study pharmacological therapy and to identify and evaluate infectious diseases, autoimmune disorders, and a variety of medical ailments.

The rising prevalence of chronic and pathogenic diseases, the aging population, the increasing popularity of point-of-care testing, and personalized medicine are anticipated to increase the demand for IVD testing in the country. Moreover, with developments in genomics & proteomics, this industry is seeing new prospects as molecular diagnostics expands its reach and introduces a new variety of condition-specific indicators and tests.

Several ailments, such as genetic, cardiovascular, and neurological disorders, are becoming more common. Cardiovascular diseases (CVDs) are the major cause of death in the U.S., killing an estimated 659,000 people each year, as per the Centers for Disease Control and Prevention (CDC). This has resulted in a significant public awareness about early diagnosis and a rise in routine diagnosis, both of which support the market's overall development.

The launch of new advanced IVD products is assisting the market's rapid expansion. Moreover, market players and research institutes are actively involved in the development of novel products to reduce the overall disease burden in the country. For instance, in May 2021, the University of California developed an ultrasensitive molecular test. This test is based on a chip technology that can detect the presence of influenza A and SARS-CoV-2 antigens. The test is under further study for conversion into a Point-of-Care (PoC) test.

The adoption of IVD testing at the point-of-care testing facilities is increasing rapidly. As several players are focusing on launching tests for home care facilities, there has been a shift in the industry dynamics. Moreover, in 2021, FDA also prioritized home-based molecular diagnostics tests. In March 2021, BATM Advanced Communications Limited announced the launch of its molecular diagnostics self-test kit for the detection of COVID-19.

The market is gaining strength as diagnostic laboratories increasingly employ fully automated tools. Automated instruments, as opposed to manual and semi-automated equipment, are more expandable, meet high level of performance, reduce technologists' hands-on time, eliminate batch testing, and provide faster results to physicians. Market participants are increasingly working on building automated instruments as a result of these benefits.

Furthermore, laboratory automation facilitates, expedites, and improves the efficiency and efficacy of diagnostic tests. From loading specimen tubes to providing findings for all major laboratory disciplines, a total lab automated system can handle all parts of the testing process. As more manufacturers enter the market with broader automation choices, the evolution of lab automation in the clinical diagnostics business is continuing to accelerate.

Since it is utilized to detect the SARS-CoV-2 virus, the COVID-19 pandemic has increased the demand for molecular diagnostics tools. Additionally, among hospitalized patients suffering from COVID-19, there was a surge in demand for test kits and consumables for measuring blood glucose levels, troponin levels, and a variety of other parameters. As a result, the usage of IVD devices increased during the pandemic and propelled the market growth.

U.S. In Vitro Diagnostics Market Report Highlights

  • By product, the reagent segment held a larger share of the U.S. IVD market owing to the increasing demand for genetic testing and the availability of advanced cancer diagnostic tests in the country
  • The coagulation segment is expected to be the fastest-growing segment. The rising prevalence of cardiovascular diseases, blood-related disorders, and autoimmune diseases is expected to boost the demand for coagulation testing
  • The oncology segment is anticipated to grow at the fastest CAGR over the forecast period owing to the increasing prevalence of disease and increasing awareness among people about early diagnosis of diseases
  • A few of the key market players include QIAGEN; F. Hoffman-La Roche Ltd.; Thermo Fisher Scientific, Inc.; Danaher Corporation; Illumina


This product will be delivered within 2 business days.

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 Research Assumptions
1.8 List Of Secondary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Segment Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 U.S. IVD Market Variables, Trends, & Scope
3.1 IVD Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Regulatory Framework
3.3 Market Driver Analysis
3.3.1 Growing Geriatric Population
3.3.2 Technological Advancements
3.3.3 Increasing Demand For Poc Facilities
3.3.4 Growing Prevalence Of Target Diseases Such As Genetic, Cardiovascular, & Neurological Diseases And Hospital-Acquired Infections
3.3.5 Outbreak Of Covid-19
3.4 Market Restraint Analysis
3.4.1 Higher Cost Of Devices
3.4.2 Stringent Regulatory Policies
3.5 Value Chain Analysis
3.5.1 Value Chain Analysis/Route To Market
3.6 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
3.7 Porter’s Five Forces Analysis
Chapter 4 U.S. IVD Market - Segment Analysis, By Product, 2018-2030 (USD Million)
4.1 U.S. In Vitro Diagnostic Market: Products Movement Analysis
4.2 Instruments
4.2.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
4.3 Reagents
4.3.1 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
4.4 Services
4.4.1 Services Market Estimates And Forecast, 2018-2030 (USD Million)
Chapter 5 U.S. IVD Market-Segment Analysis, By Technology, 2018-2030 (USD Million)
5.1 In Vitro Diagnostics Market: Technology Movement Analysis
5.2 Immunoassay
5.2.1 Immunoassay Market Estimates And Forecast, 2018-2030 (USD Million)
5.2.2 Instruments
5.2.2.1 Instruments Market For Immunoassay Estimates And Forecast, 2018-2030 (USD Million)
5.2.3 Reagents
5.2.3.1 Reagents Market For Immunoassay Estimates And Forecast, 2018-2030 (USD Million)
5.2.4 Services
5.2.4.1 Services Market For Immunoassay Estimates And Forecast, 2018-2030 (USD Million)
5.3 Hematology
5.3.1 Hematology Market Estimates And Forecast, 2018-2030 (USD Million)
5.3.2 Instruments
5.3.2.1 Instruments Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.3.3 Reagents
5.3.3.1 Reagents Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.3.4 Services
5.3.4.1 Services Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.4 Clinical Chemistry
5.4.1 Clinical Chemistry Market Estimates And Forecast, 2018-2030 (USD Million)
5.4.2 Instruments
5.4.2.1 Instruments Market For Clinical Chemistry Estimates And Forecast, 2018-2030 (USD Million)
5.4.3 Reagents
5.4.3.1 Reagents Market For Clinical Chemistry Estimates And Forecast, 2018-2030 (USD Million)
5.4.4 Services
5.4.4.1 Services Market For Clinical Chemistry Estimates And Forecast, 2018-2030 (USD Million)
5.5 Molecular Diagnostics
5.5.1 Moecular Diagnostics Market Estimates And Forecast, 2018-2030 (USD Million)
5.5.2 Instruments
5.5.2.1 Instruments Market For Molecular Diagnostics Estimates And Forecast, 2018-2030 (USD Million)
5.5.3 Reagents
5.5.3.1 Reagents Market For Molecular Diagnostics Estimates And Forecast, 2018-2030 (USD Million)
5.5.4 Services
5.5.4.1 Services Market For Molecular Diagnostics Estimates And Forecast, 2018-2030 (USD Million)
5.6 Coagulation
5.6.1 Coagulation Market Estimates And Forecast, 2018-2030 (USD Million)
5.6.2 Instruments
5.6.2.1 Instruments Market For Coagulation Estimates And Forecast, 2018-2030 (USD Million)
5.6.3 Reagents
5.6.3.1 Reagents Market For Coagulation Estimates And Forecast, 2018-2030 (USD Million)
5.6.4 Services
5.6.4.1 Services Market For Coagulation Estimates And Forecast, 2018-2030 (USD Million)
5.7 Microbiology
5.7.1 Microbiology Market Estimates And Forecast, 2018-2030 (USD Million)
5.7.2 Instruments
5.7.2.1 Instruments Market For Microbiology Estimates And Forecast, 2018-2030 (USD Million)
5.7.3 Reagents
5.7.3.1 Reagents Market For Microbiology Estimates And Forecast, 2018-2030 (USD Million)
5.7.4 Services
5.7.4.1 Services Market For Microbiology Estimates And Forecast, 2018-2030 (USD Million)
5.8 Others
5.8.1 Others Market Estimates And Forecast, 2018-2030 (USD Million)
5.8.2 Instruments
5.8.2.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
5.8.3 Reagents
5.8.3.1 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
5.8.4 Services
5.8.4.1 Services Market Estimates And Forecast, 2018-2030 (USD Million)
Chapter 6 U.S. IVD Market: Segment Analysis, By End Use, 2018-2030 (USD Million)
6.1 In Vitro Diagnostic Market: End-Use Movement Analysis
6.2 Hospitals
6.2.1 Hospitals Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2 Hospitals Market, By Technology
6.2.2.1 Immunoassay
6.2.2.2 Immunoassay Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.2.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.2.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.2.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.3 Hematology
6.2.2.4 Hematology Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.4.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.4.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.4.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.5 Clinical Chemistry
6.2.2.6 Clinical Chemistry Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.6.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.6.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.6.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.7 Molecular Diagnostics
6.2.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.8.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.8.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.8.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.9 Coagulation
6.2.2.10 Coagulation Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.10.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.10.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.10.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.11 Microbiology
6.2.2.12 Microbiology Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.12.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.12.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.12.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.13 Others
6.2.2.14 Others Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.14.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.14.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2.14.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.3 Laboratory
6.3.1 Laboratory Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2 Laboratory Market, By Technology
6.3.2.1 Immunoassay
6.3.2.2 Immunoassay Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.2.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.2.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.2.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.3 Hematology
6.3.2.4 Hematology Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.4.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.4.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.4.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.5 Clinical Chemistry
6.3.2.6 Clinical Chemistry Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.6.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.6.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.6.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.7 Molecular Diagnostics
6.3.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.8.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.8.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.8.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.9 Coagulation
6.3.2.10 Coagulation Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.10.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.10.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.10.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.11 Microbiology
6.3.2.12 Microbiology Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.12.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.12.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.12.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.13 Others
6.3.2.14 Others Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.14.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.14.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2.14.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.4 Home Care
6.4.1 Home Care Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2 Home Care Market, By Technology
6.4.2.1 Immunoassay
6.4.2.2 Immunoassay Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.2.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.2.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.2.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.3 Hematology
6.4.2.4 Hematology Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.4.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.4.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.4.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.5 Clinical Chemistry
6.4.2.6 Clinical Chemistry Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.6.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.6.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.6.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.7 Molecular Diagnostics
6.4.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.8.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.8.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.8.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.9 Coagulation
6.4.2.10 Coagulation Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.10.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.10.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.10.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.11 Microbiology
6.4.2.12 Microbiology Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.12.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.12.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.12.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.13 Others
6.4.2.14 Others Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.14.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.14.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.4.2.14.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.5 Others
6.5.1 Other Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2 Others Market, By Technology
6.5.2.1 Immunoassay
6.5.2.2 Immunoassay Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.2.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.2.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.2.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.3 Hematology
6.5.2.4 Hematology Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.4.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.4.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.4.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.5 Clinical Chemistry
6.5.2.6 Clinical Chemistry Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.6.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.6.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.6.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.7 Molecular Diagnostics
6.5.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.8.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.8.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.8.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.9 Coagulation
6.5.2.10 Coagulation Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.10.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.10.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.10.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.11 Microbiology
6.5.2.12 Microbiology Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.12.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.12.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.12.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.13 Others
6.5.2.14 Others Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.14.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.14.2 Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
6.5.2.14.3 Services Market Estimates And Forecast, 2018-2030 (USD Million)
Chapter 7 U.S. IVD Market: Segment Analysis, By Application, 2018-2030 (USD Million)
7.1 U.S. In Vitro Diagnostics Market: Application Movement Analysis
7.2 Infectious Diseases
7.2.1 Infectious Diseases Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.1 Upper Respiratory
7.2.1.1.1 Upper Respiratory Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.2 Gastrointestinal Panel Testing
7.2.1.2.1 Gastrointestinal Panel Testing Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.3 Methicillin-Resistant Staphylococcus Aureus (MRSA)
7.2.1.3.1 MRSA Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.4 Clostridium Difficile
7.2.1.4.1 Clostridium Difficile Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.5 Vancomycin-Resistant Enterococci (VRE)
7.2.1.5.1 VRE Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.6 Carbapenem-Resistant Bacteria
7.2.1.6.1 Carbapenem-Resistant Bacteria Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.7 Flu
7.2.1.7.1 Flu Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.8 Respiratory Syncytial Virus (RSV)
7.2.1.8.1 RSV Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.9 Candida
7.2.1.9.1 Candida Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.10 Tuberculosis (TB) And Drug-Resistant TB
7.2.1.10.1 TB And Drug-Resistant TB Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.11 Meningitis
7.2.1.11.1 Meningitis Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.12 Chlamydia
7.2.1.12.1 Chlamydia Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.13 Gonorrhoea
7.2.1.13.1 Gonorrhoea Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.14 HIV
7.2.1.14.1 HIV Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.15 Hepatitis C
7.2.1.15.1 Hepatitis C Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.16 Hepatitis B
7.2.1.16.1 Hepatitis B Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.1.17 Other Infectious Diseases
7.2.1.17.1 Other Infectious Disease Market Estimates And Forecast, 2018-2030 (USD Million)
7.3 Diabetes
7.3.1 Diabetes Market Estimates And Forecast, 2018-2030 (USD Million)
7.4 Oncology
7.4.1 Oncology Market Estimates And Forecast, 2018-2030 (USD Million)
7.5 Cardiology
7.5.1 Cardiology Market Estimates And Forecast, 2018-2030 (USD Million)
7.6 Nephrology
7.6.1 Nephrology Market Estimates And Forecast, 2018-2030 (USD Million)
7.7 Autoimmune Diseases
7.7.1 Autoimmune Diseases Market Estimates And Forecast, 2018-2030 (USD Million)
7.8 Drug Testing
7.8.1 Drug Testing Market Estimates And Forecast, 2018-2030 (USD Million)
7.9 Hematologic Diseases
7.9.1 Hematologic Diseases Market Estimates And Forecast, 2018-2030 (USD Million)
7.10 Others
7.10.1 Others Market Estimates And Forecast, 2018-2030 (USD Million)
Chapter 8 U.S. IVD Market: Segment Analysis, By Region, 2018-2030 (USD Million)
8.1 Regional Analysis - The U.S. IVD Market
8.1.1 Trends In The U.S. IVD Market
8.1.2 Key Country Dynamics
8.1.3 Risk Factors And Major Chronic Diseases In The U.S.
8.1.4 Competitive Scenario
8.1.5 Regulatory Framework
8.1.6 Reimbursement Scenario
8.1.7 U.S. IVD Market Estimates And Forecast, 2018-2030 (USD Million)
Chapter 9 Competitive Analysis
9.1. Participant Categorization
9.1.1. BD
9.1.1.1. Overview
9.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.1.3. Product Benchmarking
9.1.1.4. Strategic Initiatives
9.1.2. Bio-Rad Laboratories, Inc.
9.1.2.1. Overview
9.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.2.3. Product Benchmarking
9.1.2.4. Strategic Initiatives
9.1.3. Abbott
9.1.3.1. Overview
9.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.3.3. Product Benchmarking
9.1.3.4. Strategic Initiatives
9.1.4. Agilent Technologies, Inc.
9.1.4.1. Overview
9.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.4.3. Product Benchmarking
9.1.4.4. Strategic Initiatives
9.1.5. Siemens Healthcare GmbH
9.1.5.1. Overview
9.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.5.3. Product Benchmarking
9.1.5.4. Strategic Initiatives
9.1.6. Qiagen
9.1.6.1. Overview
9.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.6.3. Product Benchmarking
9.1.6.4. Strategic Initiatives
9.1.7. bioMerieux
9.1.7.1. Overview
9.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.7.3. Product Benchmarking
9.1.7.4. Strategic Initiatives
9.1.8. Quidel Corporation
9.1.8.1. Overview
9.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.8.3. Product Benchmarking
9.1.8.4. Strategic Initiatives
9.1.9. F. Hoffmann-La Roche, Ltd.
9.1.9.1. Overview
9.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.9.3. Product Benchmarking
9.1.9.4. Strategic Initiatives
9.2. Participant’s Overview
9.3. Financial Performance
9.4. Product Benchmarking
9.5. Company Market Share Analysis, 2023
9.6. Strategy Mapping
9.6.1. Expansion
9.6.2. Acquisition
9.6.3. Product/Service Launch
9.6.4. Others
Chapter 10. Analyst View
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Regulatory framework
Table 4 Current oversight of diagnostic tests
Table 5 EUA IVD tests for COVID-19 in March and April 2020 (Early Entrants)
Table 6 List of FDA approved immunoassays during early stage of pandemic
Table 7 List of key distributors
Table 8 List of key emerging companies/technology disruptors/innovators
Table 9 U.S. in vitro diagnostics market, by product, 2018-2030 (USD Million) (Volume, number of instruments and tests)
Table 10 U.S. in vitro diagnostics market, by technology, 2018-2030 (USD Million) (Volume, number of instruments and tests)
Table 11 U.S. in vitro diagnostics market, by application, 2018-2030 (USD Million)
Table 12 U.S. in vitro diagnostics market, by end-use, 2018-2030 (USD Million) (Volume, number of instruments and tests)
List of Figures
Figure 1 U.S. in vitro diagnostics market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 U.S. in vitro diagnostics market outlook (2023)
Figure 10 Parent market outlook, 2023
Figure 11 Penetration and growth prospect mapping
Figure 12 Taking control of the changing regulatory landscape
Figure 13 In vitro diagnostic market driver impact
Figure 14 Geriatric population in the U.S.
Figure 15 In vitro diagnostics market restraint impact
Figure 16 Market entry strategy
Figure 17 SWOT analysis, by factor (political & legal, economic, and technological)
Figure 18 Porter’s five forces analysis
Figure 19 Strategy mapping
Figure 20 U.S. in vitro diagnostics market: Product outlook and key takeaways
Figure 21 U.S. in vitro diagnostics market: Products movement analysis
Figure 22 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 23 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 24 Services market estimates and forecast, 2018-2030 (USD Million)
Figure 25 U.S. in vitro diagnostics market: Technology outlook and key takeaways
Figure 26 U.S. in vitro diagnostics market: Technology movement analysis
Figure 27 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 28 Instruments market for immunoassay estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 29 Reagents market for immunoassay estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 30 Services market for immunoassay estimates and forecast, 2018-2030 (USD Million)
Figure 31 Hematology market estimates and forecast, 2018-2030 (USD Million)
Figure 32 Instruments market for hematology estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 33 Reagents market for hematology estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 34 Services market for hematology estimates and forecast, 2018-2030 (USD Million)
Figure 35 Clinical chemistry market estimates and forecast, 2018-2030 (USD Million)
Figure 36 Instruments market for clinical chemistry estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 37 Reagents market for clinical chemistry estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 38 Services market for clinical chemistry estimates and forecast, 2018-2030 (USD Million)
Figure 39 Molecular diagnostics market estimates and forecast, 2018-2030 (USD Million)
Figure 40 Instruments market for molecular diagnostics estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 41 Reagents market for molecular diagnostics estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 42 Services market for molecular diagnostics estimates and forecast, 2018-2030 (USD Million)
Figure 43 Coagulation market estimates and forecast, 2018-2030 (USD Million)
Figure 44 Instruments market for coagulation estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 45 Reagents market for coagulation estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 46 Services market for coagulation estimates and forecast, 2018-2030 (USD Million)
Figure 47 Microbiology market estimates and forecast, 2018-2030 (USD Million)
Figure 48 Instruments market for microbiology estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 49 Reagents market for microbiology estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 50 Services market for microbiology estimates and forecast, 2018-2030 (USD Million)
Figure 51 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 52 Instruments others market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 53 Reagents others market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 54 Services market for other technology estimates and forecast, 2018-2030 (USD Million)
Figure 55 U.S. in vitro diagnostics market: End-use outlook and key takeaways
Figure 56 U.S. in vitro diagnostics market: End-use movement analysis
Figure 57 Hospitals market estimates and forecast, 2018-2030 (USD Million)
Figure 58 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 59 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 60 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 61 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 62 Hematology market estimates and forecast, 2018-2030 (USD Million)
Figure 63 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 64 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 65 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 66 Clinical chemistry market estimates and forecast, 2018-2030 (USD Million)
Figure 67 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 68 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 69 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 70 Molecular diagnostics market estimates and forecast, 2018-2030 (USD Million)
Figure 71 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 72 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 73 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 74 Coagulation market estimates and forecast, 2018-2030 (USD Million)
Figure 75 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 76 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 77 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 78 Microbiology market estimates and forecast, 2018-2030 (USD Million)
Figure 79 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 80 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 81 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 82 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 83 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 84 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 85 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 86 Laboratory market estimates and forecast, 2018-2030 (USD Million)
Figure 87 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 88 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 89 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 90 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 91 Hematology market estimates and forecast, 2018-2030 (USD Million)
Figure 92 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 93 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 94 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 95 Clinical chemistry market estimates and forecast, 2018-2030 (USD Million)
Figure 96 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 97 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 98 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 99 Molecular diagnostics market estimates and forecast, 2018-2030 (USD Million)
Figure 100 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 101 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 102 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 103 Coagulation market estimates and forecast, 2018-2030 (USD Million)
Figure 104 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 105 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 106 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 107 Microbiology market estimates and forecast, 2018-2030 (USD Million)
Figure 108 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 109 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 110 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 111 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 112 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 113 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 114 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 115 Home care market estimates and forecast, 2018-2030 (USD Million)
Figure 116 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 117 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 118 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 119 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 120 Hematology market estimates and forecast, 2018-2030 (USD Million)
Figure 121 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 122 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 123 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 124 Clinical chemistry market estimates and forecast, 2018-2030 (USD Million)
Figure 125 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 126 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 127 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 128 Molecular diagnostics market estimates and forecast, 2018-2030 (USD Million)
Figure 129 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 130 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 131 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 132 Coagulation market estimates and forecast, 2018-2030 (USD Million)
Figure 133 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 134 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 135 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 136 Microbiology market estimates and forecast, 2018-2030 (USD Million)
Figure 137 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 138 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 139 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 140 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 141 Instruments market estimates and forecast, 2018-2030 (USD Million) (volume, number of instruments)
Figure 142 Reagents market estimates and forecast, 2018-2030 (USD Million) (volume, number of tests)
Figure 143 Immunoassay market estimates and forecast, 2018-2030 (USD Million)
Figure 144 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 145 U.S. in vitro diagnostics market: Application outlook and key takeaways
Figure 146 U.S. in vitro diagnostics market: Application movement analysis
Figure 147 Infectious diseases market estimates and forecast, 2018-2030 (USD Million)
Figure 148 Upper respiratory market estimates and forecast, 2018-2030 (USD Million)
Figure 149 Gastrointestinal panel testing market estimates and forecast, 2018-2030 (USD Million)
Figure 150 MRSA market estimates and forecast, 2018-2030 (USD Million)
Figure 151 Clostridium difficile market estimates and forecast, 2018-2030 (USD Million)
Figure 152 VRE market estimates and forecast, 2018-2030 (USD Million)
Figure 153 Carbapenem-resistant bacteria market estimates and forecast, 2018-2030 (USD Million)
Figure 154 Flu market estimates and forecast, 2018-2030 (USD Million)
Figure 155 RSV market estimates and forecast, 2018-2030 (USD Million)
Figure 156 Candida market estimates and forecast, 2018-2030 (USD Million)
Figure 157 TB and drug-resistant TB market estimates and forecast, 2018-2030 (USD Million)
Figure 158 Meningitis cancer market estimates and forecast, 2018-2030 (USD Million)
Figure 159 Chlamydia market estimates and forecast, 2018-2030 (USD Million)
Figure 160 Gonorrhea market estimates and forecast, 2018-2030 (USD Million)
Figure 161 HIV market estimates and forecast, 2018-2030 (USD Million)
Figure 162 Hepatitis C market estimates and forecast, 2018-2030 (USD Million)
Figure 163 Hepatitis B market estimates and forecast, 2018-2030 (USD Million)
Figure 164 Other infectious disease market estimates and forecast, 2018-2030 (USD Million)
Figure 165 Diabetes market estimates and forecast, 2018-2030 (USD Million)
Figure 166 Oncology market estimates and forecast, 2018-2030 (USD Million)
Figure 167 Cardiology market estimates and forecast, 2018-2030 (USD Million)
Figure 168 Nephrology market estimates and forecast, 2018-2030 (USD Million)
Figure 169 Autoimmune diseases market estimates and forecast, 2018-2030 (USD Million)
Figure 170 Drug testing market estimates and forecast, 2018-2030 (USD Million)
Figure 171 Hematologic diseases market estimates and forecast, 2018-2030 (USD Million)
Figure 172 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 173 U.S. in vitro diagnostics market estimates and forecast, 2018-2030 (USD Million)
Figure 174 Competition categorization
Figure 175 Company market share analysis, 2023

Companies Mentioned

  • BD
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Agilent Technologies, Inc.
  • Siemens Healthcare GmbH
  • Qiagen
  • bioMerieux
  • Quidel Corporation
  • F. Hoffmann-La Roche, Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages358
PublishedDecember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 29.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 37.58 Billion
Compound Annual Growth Rate3.7%
Regions CoveredUnited States
No. of Companies Mentioned9

Related Topics

Related Reports

Global In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Forecast to 2029 - Product Image

Global In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Forecast to 2029

  • Report
  • 677 Pages
  • Global
From
North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User - Product Image

North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User

  • Report
  • 112 Pages
  • North America
From
Asia Pacific In-vitro Diagnostics Market Report and Forecast 2024-2032 - Product Image

Asia Pacific In-vitro Diagnostics Market Report and Forecast 2024-2032

  • Report
  • 150 Pages
  • Asia Pacific
From
In Vitro Diagnostics Business Outlook - Product Image

In Vitro Diagnostics Business Outlook

  • Newsletter
  • Global
From
In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes) Technology (Immunoassay, Biochemistry, Molecular Diagnostic, Microbiology, Hematology) Use (Clinical, RUO) End User - Global Forecast to 2030 - Product Image

In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes) Technology (Immunoassay, Biochemistry, Molecular Diagnostic, Microbiology, Hematology) Use (Clinical, RUO) End User - Global Forecast to 2030

  • Report
  • 389 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.